| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2000;35:914.)
© 2000 American Heart Association, Inc.
Scientific Contributions |
From the Department of Biochemistry and Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, Mass.
Correspondence to Peter Brecher, PhD, Department of Biochemistry and Whitaker Cardiovascular Institute, Boston University School of Medicine, 80 E Concord St, Boston, MA 02118. E-mail pbrecher{at}acs.bu.edu
AbstractWe have reported previously that N-acetyl-L-cysteine facilitated interleukin-1ßinduced nitric oxide synthase (iNOS) expression in rat vascular smooth muscle cells. The present study compares the effect of N-acetyl-L-cysteine with other antioxidants and tested the possibility that N-acetyl-L-cysteine potentiates iNOS induction by a mechanism involving activation of p44/42 mitogen-activated protein kinases (MAPKs). The effect of N-acetyl-L-cysteine on potentiating interleukin-1ßinduced nitrite production and iNOS expression was mimicked either by the enantiomers, L-cysteine and D-cysteine, or by a nonthiol-containing antioxidant, L-ascorbic acid. Interleukin-1ß activated p44/42 MAPK, and this activation was enhanced in the presence of N-acetyl-L-cysteine. Inhibition of p44/42 MAPK phosphorylation by the selective inhibitor PD98059 clearly inhibited iNOS expression induced by interleukin-1ß either in the absence or in the presence of N-acetyl-L-cysteine. These observations, combined with previous results, indicate that p44/42 MAPK activation is required for interleukin-1ß induction of iNOS and that N-acetyl-L-cysteine may act as a reducing agent and facilitate interleukin-1ßinduced iNOS expression through a reduction/oxidation-related mechanism involving potentiation of cytokine activation of the p44/42 MAPK signaling pathway.
Key Words: acetylcysteine interleukins nitric oxide synthase protein kinases muscle, smooth, vascular
This article has been cited by other articles:
![]() |
H. Bayat, S. Xu, D. Pimentel, R. A. Cohen, and B. Jiang Activation of Thromboxane Receptor Upregulates Interleukin (IL)-1 Induced VCAM-1 Expression Through JNK Signaling Arterioscler. Thromb. Vasc. Biol., January 1, 2008; 28(1): 127 - 134. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Qanungo, D. W. Starke, H. V. Pai, J. J. Mieyal, and A.-L. Nieminen Glutathione Supplementation Potentiates Hypoxic Apoptosis by S-Glutathionylation of p65-NF{kappa}B J. Biol. Chem., June 22, 2007; 282(25): 18427 - 18436. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ying, X. Tong, D. R. Pimentel, R. M. Weisbrod, M. P. Trucillo, T. Adachi, and R. A. Cohen Cysteine-674 of the Sarco/Endoplasmic Reticulum Calcium ATPase Is Required for the Inhibition of Cell Migration by Nitric Oxide Arterioscler. Thromb. Vasc. Biol., April 1, 2007; 27(4): 783 - 790. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Xu, H. Bayat, X. Hou, and B. Jiang Ribosomal S6 kinase-1 modulates interleukin-1beta-induced persistent activation of NF-{kappa}B through phosphorylation of I{kappa}Bbeta Am J Physiol Cell Physiol, December 1, 2006; 291(6): C1336 - C1345. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Qanungo, M. Wang, and A.-L. Nieminen N-Acetyl-L-cysteine Enhances Apoptosis through Inhibition of Nuclear Factor-{kappa}B in Hypoxic Murine Embryonic Fibroblasts J. Biol. Chem., November 26, 2004; 279(48): 50455 - 50464. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Jiang, S. Xu, X. Hou, D. R. Pimentel, and R. A. Cohen Angiotensin II Differentially Regulates Interleukin-1-{beta}-inducible NO Synthase (iNOS) and Vascular Cell Adhesion Molecule-1 (VCAM-1) Expression: ROLE OF p38 MAPK J. Biol. Chem., May 7, 2004; 279(19): 20363 - 20368. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Jiang, S. Xu, X. Hou, D. R. Pimentel, P. Brecher, and R. A. Cohen Temporal Control of NF-{kappa}B Activation by ERK Differentially Regulates Interleukin-1{beta}-induced Gene Expression J. Biol. Chem., January 9, 2004; 279(2): 1323 - 1329. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Jiang, S. Xu, P. Brecher, and R. A. Cohen Growth Factors Enhance Interleukin-1{beta}-Induced Persistent Activation of Nuclear Factor-{kappa}B in Rat Vascular Smooth Muscle Cells Arterioscler. Thromb. Vasc. Biol., November 1, 2002; 22(11): 1811 - 1816. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Satoh, A. D. Parent, and J. H. Zhang Inhibitory Effect With Antisense Mitogen-Activated Protein Kinase Oligodeoxynucleotide Against Cerebral Vasospasm in Rats Stroke, March 1, 2002; 33(3): 775 - 781. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Jiang, P. Brecher, and R. A. Cohen Persistent Activation of Nuclear Factor-{kappa}B by Interleukin-1{beta} and Subsequent Inducible NO Synthase Expression Requires Extracellular Signal-Regulated Kinase Arterioscler. Thromb. Vasc. Biol., December 1, 2001; 21(12): 1915 - 1920. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R. Standley, M. A. Stanley, and P. Senechal Activation of mitogenic and antimitogenic pathways in cyclically stretched arterial smooth muscle Am J Physiol Endocrinol Metab, December 1, 2001; 281(6): E1165 - E1171. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Cherla and R. K. Ganju Stromal Cell-Derived Factor 1{{alpha}}-Induced Chemotaxis in T Cells Is Mediated by Nitric Oxide Signaling Pathways J. Immunol., March 1, 2001; 166(5): 3067 - 3074. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |